ETAC Trademark
Trademark Overview
On Friday, October 18, 2024, a trademark application was filed for ETAC with the United States Patent and Trademark Office. The USPTO has given the ETAC trademark a serial number of 98808633. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 24, 2025. This trademark is owned by Heidelberg Pharma Research GmbH. The ETAC trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations; Pharmaceuticals; Chemicopharmaceutical preparations; Pharmaceutical preparations and substances; Pharmaceutical preparations for veterinary use; Chemical preparations for pharmaceutical purposes; Pharmaceutical preparations for human use; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical use; Diagnostic preparations for veterinary purposes; Clinical diagnostic reagents; Diagnostic chemical reagents for medical use; Anti-cancer drugs; Compounds for treating cancer; Anti-cancer preparations; Anti-cancer preparations of chemical origin; Biopharmaceuticals for the treatment of cancer; Pharmaceutical prepa...
Pharmaceutical services in the field of oncology; Pharmaceutical advice; Pharmaceutical services; Consultancy and information services relating to pharmaceutical products; Providing healthcare information regarding cancer drugs and cancer treatment
Pharmaceutical research services; Medical and pharmacological research services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Provision of research services; Scientific research; Medical research; Biomedical research services; Research relating to biotechnology; Research on the subject of pharmaceuticals; Consultancy relating to research in the field of pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of diagnostic preparations; Research and development in the field of biotechnology; Research and development for the pharmaceutical industry; Research and development services in the field of antibody technology; Research and development services in the field of antibodies and antibody-drug conjugates; Laboratory services relating to the production of monoclonal antibodies and antibody-drug conjug...
General Information
| Serial Number | 98808633 |
| Word Mark | ETAC |
| Filing Date | Friday, October 18, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Thursday, April 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations; Pharmaceuticals; Chemicopharmaceutical preparations; Pharmaceutical preparations and substances; Pharmaceutical preparations for veterinary use; Chemical preparations for pharmaceutical purposes; Pharmaceutical preparations for human use; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical use; Diagnostic preparations for veterinary purposes; Clinical diagnostic reagents; Diagnostic chemical reagents for medical use; Anti-cancer drugs; Compounds for treating cancer; Anti-cancer preparations; Anti-cancer preparations of chemical origin; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Chemotherapeutics; Antibodies; Antibody-drug conjugates |
| Goods and Services | Pharmaceutical services in the field of oncology; Pharmaceutical advice; Pharmaceutical services; Consultancy and information services relating to pharmaceutical products; Providing healthcare information regarding cancer drugs and cancer treatment |
| Goods and Services | Pharmaceutical research services; Medical and pharmacological research services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Provision of research services; Scientific research; Medical research; Biomedical research services; Research relating to biotechnology; Research on the subject of pharmaceuticals; Consultancy relating to research in the field of pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of diagnostic preparations; Research and development in the field of biotechnology; Research and development for the pharmaceutical industry; Research and development services in the field of antibody technology; Research and development services in the field of antibodies and antibody-drug conjugates; Laboratory services relating to the production of monoclonal antibodies and antibody-drug conjugates |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 18, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 18, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 18, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Heidelberg Pharma Research GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Ladenburg 68526
DE |
Trademark Events
| Event Date | Event Description |
| Friday, October 18, 2024 | NEW APPLICATION ENTERED |
| Monday, April 21, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 22, 2025 | ASSIGNED TO EXAMINER |
| Thursday, April 24, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, April 24, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, April 24, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
